The conference will for the 4th time convene an exchange platform for all actors – academia, parents and survivors, industry and regulators, policymakers and charities – to evaluate progress and define further steps to foster more and better cure, including with regards to the paediatric medicines legislation.

The 2016 conference will share progresses and discuss the following proposals made by the working groups:

• New strategies for improved development of oncology drugs for children and adolescents
• Mechanism of action based development strategy
• Compound prioritisation
• Changes needed in the paediatric medicine regulation
• New incentives for specific paediatric drug development and drug repositioning.
• Implementation of long-term follow up measures of children and adolescents receiving new anticancer drugs.
• Recent successes in new drug development will be shared.